Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  St Jude Medical Inc    STJ

ST JUDE MEDICAL INC (STJ)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesNewsCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

St. Jude Medical, Inc. : St Jude To Stop Selling Another Version Of Defibrillator Wires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/04/2012 | 03:48pm CEST

St. Jude Medical Inc. (STJ) will stop selling another version of its defibrillator wires in an effort to head off potential problems like those the medical-device maker is currently battling with its Riata and Riata ST wires.

The Riata defibrillator wires, called leads, are no longer on the market but are still implanted in thousands of patients in the U.S. In a medical journal last month, prominent cardiologist Robert G. Hauser wrote that the cables are responsible for at least 20 deaths.

Wednesday, the company said it will cease selling its QuickSite and QuickFlex left-ventricular leads used to connect cardiac resynchronization therapy devices to the heart. Roughly 171,000 QuickSite and QuickFlex leads have been sold worldwide.

The decision comes as St. Jude has confirmed 39 cases of the metal wires wearing through their silicone covering, leading to an incidence rate of 2.3 in every 10,000 leads. Still, it stressed that its decision to stop selling the wires is a proactive one.

"It is important to note, however, that the overall safety and reliability of QuickSite and QuickFlex leads continues to be comparable to currently available CRT leads from other manufacturers," the company wrote.

The wire leads connect life-saving medical devices, which are placed under the skin in the shoulder area, to the heart and delivers a jolt that restores proper rhythm. Because of the constant pounding motion of the heart, the thin leads can be damaged.

Shares closed Tuesday at $43.80 and were inactive in premarket trading. The stock is up roughly 36% from lows hit late last year when the Food and Drug Administration termed the Riata defibrillator issues as a Class I recall, which applies to grave dangers like chance of death.

 
   -By Mia Lamar, Dow Jones Newswires; 212-416-3207; [email protected] 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ST JUDE MEDICAL INC
2017ST JUDE MEDICAL : $12,244 Federal Contract Awarded to St. Jude Medical
AQ
2017ST JUDE MEDICAL : Federal Contracts Awarded by Federal Agencies in Indiana (Nov...
AQ
2017ST JUDE MEDICAL : Federal Contracts Awarded to Companies in Minnesota (Nov. 9)
AQ
2017ST JUDE MEDICAL : $35,241 Federal Contract Awarded to St. Jude Medical
AQ
2017ST JUDE MEDICAL : 65-- VAAAHS St. Judes HV IDIQ
AQ
2017ST JUDE MEDICAL : Twiddler’s syndrome presenting as life threatening elect..
AQ
2017ABBOTT LABORATORIES : Reports Third Quarter 2017 Results
AQ
2017ST JUDE MEDICAL : Patent Issued for Surgical Heart Valve Flexible Stent Frame St..
AQ
2017ST JUDE MEDICAL : "Leaflet-Cuff Attachments for Prosthetic Heart Valve" in Paten..
AQ
2017ST JUDE MEDICAL : Patent Issued for Catheter with Atraumatic Tip (USPTO 9649155)
AQ
More news
News from SeekingAlpha
2017Medical Device Firm Hancock Jaffe Laboratories Files Terms For $20 Million IP.. 
2017DIVIDEND STREAKS IN DANGER : 2016 Review And 2017 Preview 
2017Abbott-Alere Deal To Go Ahead 
2017GLAZER CAPITAL : Merger Arbitrage With Convertibles - A Lower Risk Alternative 
2017Panel To Stand Sentinel Over Embolic Filter 
Managers
NameTitle
Michael T. Rousseau President, Chief Executive Officer & Director
Scott P. Thome Vice President-Global Operations & Supply Chain
Mark D. Carlson Chief Medical Officer & VP-Global Clinical Affairs
Mark W. Murphy Chief Information Officer & Vice President-IT
Philip J. Ebeling Chief Technology Officer & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ST JUDE MEDICAL INC0.00%0
STRYKER CORPORATION13.29%65 414
SMITH & NEPHEW4.58%15 726
WRIGHT MEDICAL GROUP NV12.16%2 631
JAPAN LIFELINE CO., LTD.11.25%2 171
GLAUKOS CORP34.50%1 239